Whitmore Bradford T
CIK 0000933430
Director10% Owner
Filings
31
Latest May 26, 2026
Issuers covered
3
Showing
31 of 31
Page 1
Track record
52 of 68 open-market trades scored (76% price coverage) - 16 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 52 | 69% | +6.8% | +5.6% | +54.4% | -16.8% |
| 90 days | 49 | 67% | +42.6% | +21.8% | +190.2% | -30.3% |
| 180 days | 46 | 65% | +50.3% | +46.9% | +200.0% | -45.8% |
| 365 days | 37 | 78% | +105.4% | +20.9% | +454.9% | -24.8% |
Issuers
Companies where Whitmore Bradford T has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ULBI | Ultralife Corp | 21 | May 26, 2026 |
| NANX | Nanophase Technologies Corp | 8 | Jun 2, 2025 |
| CLSD | Clearside Biomedical, Inc. | 2 | Feb 9, 2024 |
All filings
31 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|